| HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
0.6 |
Evidence |
|
| PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
JAK1 |
|
0.6 |
Evidence |
|
| PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
0.6 |
Evidence |
|
| PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.6 |
Evidence |
|
| GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
TSHR |
IPI00386365 |
0.6 |
Evidence |
|
| EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
CNTN2 |
CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor |
0.6 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
KLK6 |
KLK6, PRSS18, PRSS9: Kallikrein-6 precursor |
0.6 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
0.6 |
Evidence |
|
| PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
0.6 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
0.6 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
0.6 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
0.6 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.6 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.6 |
Evidence |
|
| SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
KLK6 |
KLK6, PRSS18, PRSS9: Kallikrein-6 precursor |
0.6 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
0.6 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
GNAI2 |
Galphai2 protein |
0.6 |
Evidence |
|
| GLRA1 |
IPI00011565 |
GLRB |
GLRB: Glycine receptor subunit beta precursor |
0.6 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.6 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.6 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
0.6 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.6 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.6 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
0.6 |
Evidence |
|
| LPA |
LPA: Apolipoprotein(a) precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
0.6 |
Evidence |
|